Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.730
-0.100 (-2.07%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $269.65 million as of August 21, 2026. Its market cap has increased by 246.77% in one year.
Market Cap
269.65M
Enterprise Value
79.67M
1-Year Change
246.77%
Ranking
Category
Stock Price
$4.73
ChartMarket Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $269.65M, a decrease of -50.14%. That is a compound annual growth rate of -13.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 269.65M | 136.43% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 278.44M |
| Lineage Cell Therapeutics | 273.14M |
| Entrada Therapeutics | 269.71M |
| Adagene | 268.57M |
| Sol-Gel Technologies | 261.32M |
| Pyxis Oncology | 258.15M |
| MacroGenics | 257.99M |
| Niagen Bioscience | 255.32M |